Zhi Li | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Zhi Li | Molecular and Cellular Neuroscience | Best Researcher Award

Assist. Prof. Dr. Zhi Li | Qinghai University | China

Zhi Li is a researcher specializing in cellular biology, infection and immunity, host–pathogen interactions, vector and vector-borne diseases, and zoonoses. His work focuses on understanding the molecular mechanisms underlying host responses to parasitic infections and the epidemiology of emerging infectious diseases in animals. As an Assistant Professor at Qinghai University, he has contributed significantly to research on parasitic pathogens affecting livestock and wildlife in the Qinghai-Tibetan Plateau region. His studies have explored infections caused by Echinococcus shiquicus, Theileria annulata, and various fluke species, emphasizing their identification, transmission dynamics, and host interactions. Through collaborations with national and international researchers, he has published in leading journals such as Transboundary and Emerging Diseases, Parasitology Research, Parasites & Vectors, and Acta Tropica. His research integrates molecular biology, immunological assays, and field epidemiology to develop improved diagnostic tools and better understand pathogen adaptation in diverse ecological settings. By linking laboratory findings with field observations, Zhi Li’s work contributes to controlling zoonotic and vector-borne diseases that threaten both animal and human health, aligning with the global “One Health” approach that connects veterinary and biomedical research for sustainable disease management.

Profile: Orcid

Li, Z., Han, Y., Liu, J.-L., Zhang, X.-Y., Shen, X., Guo, Z.-H., Yin, H., Duo, H., & Fu, Y. (2025). High diversity of Piroplasm species carried by ticks from Qinghai, China. Acta Tropica, 250, 107907.

Fu, Y., Zhang, X., Li, Z., Shi, Z., Ma, X., Meng, R., Zhang, Q., Zhao, C., Guo, S., Ma, W., et al. (2023, November 23). Emerging Echinococcus shiquicus infection of Asian badgers in the Qinghai–Tibetan Plateau. Transboundary and Emerging Diseases, 2023, 6874033.

Fu, Y., Zhang, X., Li, Z., Meng, R., Duo, H., Shen, X., Ma, Y., & Guo, Z. (2023, July). Identification and prevalence of fluke infection in yak and Tibetan sheep around Qinghai Lake, China. Parasitology Research.

Zhang, X., Jian, Y., Li, Z., Duo, H., Guo, Z., & Fu, Y. (2023, February 25). Optimization of single-tube nested PCR for the detection of Echinococcus spp. Experimental Parasitology, 246, 108358.

Liu, J., Zhao, S., Li, Z., Zhang, Z., Zhao, B., Guan, G., Yin, H., & Luo, J. (2023, February 23). Activation of telomerase activity and telomere elongation of host cells by Theileria annulata infection. Frontiers in Microbiology, 14, 1123456.

Gokhan Uyanık | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Gokhan Uyanık | Neuropharmacology | Best Researcher Award

Assist. Prof. Dr. Gokhan Uyanık | Hatay Mustafa Kemal University | Turkey

Assistant Professor Gokhan Uyanık is a faculty member in the Department of Obstetrics and Gynecology at the Faculty of Veterinary Medicine, Hatay Mustafa Kemal University, Turkey. His academic expertise lies in veterinary obstetrics and gynecology, with a particular focus on reproductive physiology and fertility enhancement in small ruminants. His doctoral research explored the effects of GnRH and TAK-683 administration on fertility following estrus synchronization during the anestrus period in ewes, contributing to advancements in reproductive management and animal breeding efficiency. He has actively engaged in undergraduate teaching, guiding clinical applications and practical veterinary training in obstetrics and gynecology. Dr. Uyanık has authored 5 scientific documents that have received 7 citations, reflecting his growing contribution to the veterinary reproductive science community. His h-index stands at 2, indicating a developing yet impactful research trajectory. Through his integration of clinical practice, teaching, and experimental research, he aims to enhance understanding and management of reproductive disorders in animals. His academic presence is supported by international researcher identifiers, including ORCID and Scopus, ensuring global visibility and collaboration within the scientific community.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Gozer, A., Uyanik, G., Keceli, H. H., Kaya, U., and Ozkan, H. (2025). Upregulation of miR-125b and miR-23b in plasma might be related with the early pregnancy in Awassi ewes. Small Ruminant Research, 107579.

Cerci, E., Saribay, M. K., and Uyanik, G. (2025). Ineklerde Vitamin A, D ve E’nin fertilite uzerine etkisi: Derleme. Bahri Dagdas Hayvancilik Arastirma Dergisi, 14(1), 28–43.

Gozer, A., Bahan, O., Uyanik, G., Kaya, U., Arslanhan, E., Kucukkara, B., and Tatar, G. (2025). The effects of prepartum vitamin E/selenium and melatonin treatment on uterine involution of Awassi sheep in Hatay. Kocatepe Veterinary Journal, 18(2), 104–111.

Uyanik, G. and Gozer, A. (2025). Effect of different doses of equine chorionic gonadotrophin on the pregnancy rates in the Awassi ewes in out-of-breeding season. 9th International Congress on Veterinary and Animal Sciences, 105–106.

Uyanik, G. (2024). Koyunlarda anostrus doneminde ostrus senkronizasyonu sonrasi GnRH veya TAK-683 uygulamasinin fertiliteye etkisi. Master’s thesis, Erciyes University, Institute of Health Sciences, Department of Veterinary Obstetrics and Gynecology.

Kose, S. I., Erturk, A., Uyanik, G., and Ozturk, A. S. (2024). Evaluation of relationship between C-reactive protein, leukocyte count and platelet indices in dogs with leukocytosis. Kocatepe Veterinary Journal, 17(3), 270–279.

Kose, S. I., Ozturk, A. S., Uyanik, G., Erturk, A., and Durgut, R. (2023). What is the latest status of cats’ health in Hatay (Turkey) province following the SARS-CoV-2 pandemic? Kocatepe Veterinary Journal, 16(3), 450–458.

Uyanik, G., Kose, S. I., and Ozturk, A. S. (2021). Can rheumatoid factor use in the diagnosis of osteomalacia in dogs: A case report.

Hui Zhang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Northwestern University | United States

Hui Zhang is a Professor in the Division of Biostatistics, Department of Preventive Medicine at Northwestern University Feinberg School of Medicine, where he also holds appointments at the Robert H. Lurie Comprehensive Cancer Center, the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and the Center for Epidemiology and Population Health. he serves as Director of the Northwestern Brain Tumor SPORE Biostatistics and Bioinformatics Core and leads the Biostatistics and Data Management Core at the Mesulam Center. With a Ph.D. in Statistics from the University of Rochester, her academic foundation spans pharmacology, neurophysiology, and biology, reflecting her interdisciplinary expertise in biostatistics and biomedical research. His previous experience includes research roles at St. Jude Children’s Research Hospital, where she contributed significantly to clinical and statistical protocol development. Professor Zhang’s work focuses on statistical methodologies for cancer and neurological disease research, data integration, and bioinformatics applications. he is an active member of several professional societies, including the American Statistical Association and the International Chinese Statistical Association. A highly cited researcher, she has accumulated over 11,422 citations, an h-index of 43, and an i10-index of 100, demonstrating her substantial impact and leadership in the fields of biostatistics and medical data science.

Profile: Google Scholar

Featured Publications

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361(14), 1329–1338.

Gunzler, D., Chen, T., Wu, P., & Zhang, H. (2013). Introduction to mediation analysis with structural equation modeling. Shanghai Archives of Psychiatry, 25(6), 390–394.

Wan, T., Jun, H. U., Pan, W. U., & Hua, H. E. (2015). Kappa coefficient: A popular measure of rater agreement. Shanghai Archives of Psychiatry, 27(1), 62–67.

Pu, J., Wang, S., Yin, Y., Zhang, G., Carter, R. A., Wang, J., Xu, G., Sun, H., Wang, M., et al. (2015). Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences, 112(2), 548–553.

Guy, C. S., Vignali, K. M., Temirov, J., Bettini, M. L., Overacre, A. E., Smeltzer, M., et al. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology, 14(3), 262–270.

Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., Hu, S., Zhai, X., Liang, C., Ju, X., Jiang, H., et al. (2020). Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncology, 6(3), 358–366.

Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., et al. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: A phase 1 trial. The Lancet Oncology, 24(5), 509–522.

William Blumentals | Clinical Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Dr. William Blumentals | Clinical Neuroscience | Excellence in Research Award

Dr. William Blumentals | Sanofi | United States

Dr. William A. Blumentals is an accomplished epidemiologist and pharmaceutical executive recognized for his leadership in pharmacoepidemiology, real-world evidence generation, and global health outcomes research. He serves as Associate Vice President and Head of Specialty Care Pharmacoepidemiology at Sanofi in Cambridge, Massachusetts, where he oversees a multinational team of epidemiologists across the United States and Europe, driving innovation in inflammation, immunology, oncology, and rare disease research. With a Ph.D. in Epidemiology from the University of South Florida, along with advanced degrees in Statistics, Epidemiology, and Biology, Dr. Blumentals has held senior positions at leading organizations including Shire Pharmaceuticals, Shionogi Inc., and Hoffmann-La Roche. His expertise spans strategic development of large-scale observational studies, organizational leadership, and cross-functional collaboration to optimize evidence-based decision-making in healthcare. As a thought leader in real-world evidence and outcomes research, he has contributed significantly to advancing global epidemiological practices. Dr. Blumentals has authored 36 scientific documents, accumulated 1,594 citations from 1,463 documents, and holds an h-index of 23, reflecting his strong scientific influence and impact in epidemiology and pharmaceutical research.

Profile: Scopus

Featured Publications

Multiple sclerosis and the association with inflammatory bowel disease: Results from a retrospective cohort study. (2025). Multiple Sclerosis and Related Disorders.


Cytokine release syndrome risk model with T-cell engaging therapies. (2025). Cytotherapy.


Evaluating the accuracy of responses by large language models for information on disease epidemiology. (2025). Pharmacoepidemiology and Drug Safety.

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Nobuhiro Inoue | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Nobuhiro Inoue | Neuropharmacology | Best Researcher Award

Dr. Nobuhiro Inoue | Kumamoto Neurosurgical Hospital | Japan

Dr. Nobuhiro Inoue is a distinguished neurosurgeon affiliated with Kumamoto Neurosurgical Hospital in Japan, recognized for his extensive contributions to the field of neurosurgery and neurological research. His clinical expertise encompasses advanced microsurgical techniques, neurotrauma management, cerebrovascular disorders, and brain tumor surgery. Dr. Inoue has published numerous scientific papers in reputable international journals, reflecting his commitment to advancing medical knowledge and improving neurosurgical outcomes. His research often focuses on the pathophysiology of brain and spinal diseases, the development of minimally invasive surgical methods, and innovative neuroimaging applications in clinical practice. As an active contributor to academic and clinical advancements, Dr. Inoue collaborates with interdisciplinary teams to integrate cutting-edge technology and evidence-based approaches in patient care. His scientific works have been widely cited, underscoring their influence on neurosurgical research and education. Through his dedication to both surgery and scientific inquiry, Dr. Nobuhiro Inoue continues to play a vital role in enhancing the understanding and treatment of complex neurological conditions in Japan and beyond.

Profile: Orcid

Featured Publications

Inoue, N., & Goto, S. (2025). Clinical evidence of senile choreo-athetosis following valproate withdrawal: A case report. Neurology and Clinical Neuroscience.

Inoue, N. (2020). Post-stroke dizziness of visual vestibular cortices origin. Journal of Neuroscience and Neurological Disorders.

Inoue, N. (2017). Severe ischemic stroke due to progression of cervical carotid artery dissection. Neurological Research and Therapy, 17(22).

Inoue, N. (2015). Cerebral blood flow in the visual and parieto-insular vestibular cortices in patients after cerebral ischemia with or without dizziness. International Journal of Neurological Disorders & Interventions, 101.

Inoue, N. (2014). Effect of ibudilast on the reciprocal inhibitory visual-vestibular interaction closely related to dizziness after cerebral ischemia. Journal of Stroke and Cerebrovascular Diseases, 23, 51–55.

Inoue, N. (2011). Highly purified eicosapentaenoic acid improves cerebral vasomotor-reactivity in patients with chronic cerebral ischemia. Therapeutic Research, 32, 1325–1332.

Inoue, N. (2010). Long-term suppression of Meige syndrome after pallidal stimulation: A 10-year follow-up study. Movement Disorders, 25(11), 1753–1763.

Inoue, N. (2009). Relationship between dizziness and cerebral blood flow in patients with chronic cerebral ischemia. In A. Lindqvist & G. Nyman (Eds.), Dizziness: Vertigo, disequilibrium and lightheadedness. Nova Science Publishers. ISBN 978-1-60741-847-4

Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award

Published on by Neuroscientists

Dr. Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award 

Dr. Kathrin Eichinger | Medizinische Universitat Wien | Austria

Dr. Med. Kathrin Eichinger is an Austrian physician specializing in Pediatrics and Pediatric Neurology, currently serving as a Consultant in Child and Adolescent Medicine with subspecialty training in Neuropediatrics at the Medical University of Vienna. Her clinical and academic focus lies in neuroimmunology, with ongoing doctoral research in neuroscience examining acute necrotizing encephalitis. Dr. Eichinger’s experience spans several leading medical institutions, including Sankt Anna Children’s Hospital and the Hospital of the Brothers of Mercy in Eisenstadt, complemented by an observership in Neurointensive Care and Neuroimmunology at the Children’s Hospital of Philadelphia. She has also contributed to clinical research through her involvement in the eSMART randomized controlled trial on electronic symptom management at the Medical University of Vienna. Her expertise is further supported by certification in pediatric EEG and active participation in numerous neuropediatric congresses and workshops across Europe. Multilingual in German, English, and Spanish, Dr. Eichinger combines her clinical acumen with strong research engagement, reflected in her growing academic footprint with an h-index of 3, five peer-reviewed documents, and approximately 45 citations. Her professional pursuits integrate advanced clinical training, translational neuroscience, and a dedication to improving pediatric neurocare.

Profile: Orcid

Featured Publications

  • Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., Kornek, B., et al. (2025). Complications of therapeutic plasma exchange in pediatric neuroimmune disorders. Children, 12(11), 1457.

  • Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., et al. (2021). Management and outcome of vagus nerve stimulator implantation: Experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology, 278(10), 3729–3738.

Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Dr. Seyyed Ali | Zendehbad University of Mazandaran | Iran

Dr. Seyyed Ali Zendehbad is a multidisciplinary researcher specializing in biomedical signal processing, cognitive computational neuroscience, and neurorehabilitation technologies. His research integrates deep learning, pattern recognition, and multimodal biological data modeling to enhance fatigue detection and neurorehabilitation systems. He has authored several peer-reviewed papers in reputable journals such as Scientific Reports, IEEE Access, Sensing and Bio-Sensing Research, and Healthcare Technology Letters, focusing on hybrid AI frameworks, EMG signal processing, and muscle synergy-based biofeedback mechanisms. Dr. Zendehbad’s work on developing intelligent rehabilitation systems, including his models like TraxVBF and FatigueNet, contributes to advancing telemonitoring and assistive technologies for neurological recovery. His scholarly output includes more than 25 documents, over 600 citations, and an h-index of 12, reflecting his growing impact in computational neuroscience and biomedical engineering. Recognized for innovation, he has achieved first-place awards in multiple national startup competitions and was honored with the Best Poster Award at the Congress of Neurology and Clinical Electrophysiology of Iran. As a postdoctoral researcher at the University of Mazandaran, his ongoing work emphasizes integrating trustworthy AI into telehealth systems, promoting equitable and efficient digital healthcare delivery through interdisciplinary research and technological innovation.

Profile: Orcid

Featured Publications

1. Mazrooei Rad, E., Mazinani, S. M., & Zendehbad, S. A. (2025). Diagnosis of Alzheimer’s disease using non-linear features of ERP signals through a hybrid attention-based CNN-LSTM model. Computer Methods and Programs in Biomedicine Update, 5, 100192.

2. Zendehbad, S. A., Sharifi Razavi, A., Tabrizi, N., & Sedaghat, Z. (2025). A systematic review of artificial intelligence techniques based on electroencephalography analysis in the diagnosis of epilepsy disorders: A clinical perspective. Epilepsy Research, 207, 107582.

3. Mazrooei Rad, E., Zendehbad, S. A., & Hosseinzadeh, V. (2025). Fetal QRS complex detection based on adaptive filters and peak detection. Research on Biomedical Engineering, 41(3), 424–438.

4. Zendehbad, S. A., Ghasemi, J., & Samsami Khodadad, F. (2025). FatigueNet: A hybrid graph neural network and transformer framework for real-time multimodal fatigue detection. Scientific Reports, 15(1), 640.

5. Safdel, A., Zendehbad, S. A., & Ghasemi, J. (2025). Advanced deep learning approaches for accurate and efficient suspicious behavior detection in surveillance videos. Computational Sciences and Engineering, 21(2), 1099.

Maria -Camelia Stancioaica | Clinical Neuroscience |

Published on by Neuroscientists

Ms. Maria -Camelia Stancioaica | Clinical Neuroscience | Best Researcher Award

Ms. Maria -Camelia Stancioaica | Fundeni Clinical Hospital | Romania

Dr. Maria Camelia Stăncioaica is a dedicated Romanian hematologist affiliated with the Fundeni Clinical Institute in Bucharest, where she serves as the Acute Leukemia Program Coordinator. She holds an M.D. in Clinical Hematology and is currently pursuing her Ph.D. at the Carol Davila University of Medicine. Her professional development includes international experience through observership at Johns Hopkins Hospital in the USA and an internship at Pitié–Salpêtrière Hospital in France. Dr. Stăncioaica has contributed to advancing hematologic research through publications addressing acute leukemia, fungal infections in immunocompromised patients, and targeted therapies in acute myeloid leukemia. Her notable works include studies on FLT3 inhibitors, differentiation syndrome in pregnancy, and invasive fusariosis outbreaks. Actively engaged in global scientific dialogue, she has been a speaker and session chair at prominent hematology conferences across Europe. She also participates in several clinical trials as both principal and subinvestigator, focusing on novel therapeutic strategies in leukemia management. Dr. Stăncioaica’s research achievements are reflected in her 21 citations, 2 h-index, and 1 i10-index, underscoring her growing influence in clinical hematology. She is a member of the European Hematology Association and the Romanian Society of Hematology, contributing to both national and international medical communities.

Profile: Google Scholar

Featured Publications

1. Ghiaur, A., Doran, C., Gaman, M. A., Ionescu, B., Tatic, A., Cirstea, M., … Stancioaica, M. C. (2024). Acute promyelocytic leukemia: Review of complications related to all-trans retinoic acid and arsenic trioxide therapy. Cancers, 16(6), 1160.

2. Mohorea‐Neata, A. L., Ghita, M. C., Moroti, R., Ghiaur, A., Ionescu, B., Tatic, A., … Stancioaica, M. C. (2023). Invasive fusariosis in acute leukaemia patients—An outbreak in the haematology ward. Mycoses, 66(8), 705–710.

3. Droc, G., Stancioaica, M. C., Soare, C. G., Stefan, M. G., Ingustu, D., Martac, C., … Ghiaur, A. (2023). Acute promyelocytic leukemia and severe differentiation syndrome in pregnancy—A management challenge. Life, 13(5), 1141.

4. Coriu, D., & Stancioaica, M. C. (2023). Moving low-risk myelodysplastic syndromes from humans to mice: Is it truly that simple? Haematologica, 109(1), 8.

5. Stancioaica, M. C., Coriu, D., & Ghiaur, G. (2025). FLT3: A 35-year voyage from discovery to the next generation of targeted therapy in AML. Cancers.

Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jane Paulsen | University of Wisconsin Madison | United States

Dr. Jane S. Paulsen, Ph.D., is a Professor of Neurology and Vice Chair for Research at the University of Wisconsin–Madison, where she also contributes to the Department of Neurosciences Graduate Program. Her expertise lies in cognitive, psychiatric, and imaging correlates of neuropsychiatric disorders, with a strong focus on the early detection of brain diseases and the development of innovative methods for clinical trials. She has significantly advanced the understanding of genetic discrimination and the discovery and validation of biological and clinical markers of brain disease, incorporating neuroimaging and omics-based outcomes into her research. Dr. Paulsen completed her Ph.D. in Counseling Psychology at the University of Iowa, followed by postdoctoral training in Neuropsychology at the University of California, San Diego, where she worked on Alzheimer’s and geriatric psychiatry research. Over her career, she has held key positions including Director of the Huntington’s Disease Clinical Research Program at UCSD and has contributed extensively to advancing neuropsychological research and clinical applications. Her scholarly impact includes 4 published documents, 78 citations from 77 documents, and an h-index of 3, reflecting her influence in the fields of neurology, neuropsychology, and cognitive neuroscience.

Profiles: Scopus | Google Scholar | Reserach Gate | linked In

Featured Publications

Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014). Classifying neurocognitive disorders: The DSM-5 approach. Nature Reviews Neurology, 10(11), 634–642.

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204–216.

Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., & Shoulson, I. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880.

Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & International Huntington’s Disease Collaborative Group. (2004). A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clinical Genetics, 65(4), 267–277.

Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., & Paulsen, J. S. (1998). Apathy is not depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 314–319.

Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., & Paulsen, J. S. (2014). Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Disease & Associated Disorders, 28(3), 206–218.

Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Braff, D., Harris, M. J., & Zisook, S. (1997). Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology, 11(3), 437–446.

Plis, S. M., Hjelm, D. R., Salakhutdinov, R., Allen, E. A., Bockholt, H. J., Long, J. D., & Calhoun, V. D. (2014). Deep learning for neuroimaging: A validation study. Frontiers in Neuroscience, 8, 229.

Mohamed, S., Paulsen, J. S., O’Leary, D., Arndt, S., & Andreasen, N. (1999). Generalized cognitive deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry, 56(8), 749–754.

Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S., & Cummings, J. L. (2001). Neuropsychiatric aspects of Huntington’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 71(3), 310–314.